11:10 AM EDT, 04/17/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower Wednesday morning, falling 0.3% to 1,330.47 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Calliditas Therapeutics (CALT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which rose 4.6% and 3.1% respectively. They were followed by internet advertising firm Criteo (CRTO) and biopharmaceutical company DBV Technologies (DBVT), which were up 3.4% and 0.03% respectively.

The decliners from continental Europe were led by biopharmaceutical company Genfit (GNFT) and semiconductor company Sequans Communications (SQNS), which fell 3.7% and 2.5% respectively. They were followed by biopharmaceutical company argenx (ARGX) and biotech firm Biophytis (BPTS), which dropped 2.4% and 2% respectively.

From the UK and Ireland, the gainers were led by mining company BHP Group (BHP) and biopharmaceutical company Akari Therapeutics (AKTX), which increased 3.7% and 3.5% respectively. They were followed by biopharmaceutical companies Amarin (AMRN) and NuCana (NCNA), which rose 2.7% and 2% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Biodexa Pharmaceuticals (BDRX), which were down 3% and 2.2% respectively. They were followed by pharmaceutical company Avadel Pharmaceuticals (AVDL) and biotech firm Trinity Biotech (TRIB), which fell 2% and 1.5% respectively.

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.